• Berbamine hydrochloride: NF-κB Activity Inhibition in Cancer

  2026-06-30

  Berbamine hydrochloride delivers precision NF-κB activity inhibition and robust cytotoxicity in challenging oncology workflows, notably in leukemia and hepatocellular carcinoma models. This guide details experimental workflows, protocol refinements, and troubleshooting tips, translating the latest findings on ferroptosis resistance into actionable research strategies.

• SB 431542: A Next-Generation Tool for Dissecting EMT and TGF

  2026-06-29

  Explore the advanced scientific underpinnings of SB 431542, a potent ALK5 inhibitor, and its pivotal role in epithelial-to-mesenchymal transition (EMT) and TGF-β signaling research. This article uniquely connects molecular inhibition to practical assay advances and recent breakthroughs in endometriosis models.

• Sprayable Etoposide Nanoparticles for Localized Brain Tumor

  2026-06-29

  The referenced study introduces a sprayable hydrogel system delivering etoposide and olaparib nanoparticles directly to brain tumor resection sites. This localized delivery approach demonstrates improved drug retention, biocompatibility, and potential to overcome limitations of systemic chemotherapy in glioblastoma models.

• Enhanced ECL Chemiluminescent Substrate Detection Kit: Quant

  2026-06-28

  Explore how the ECL Chemiluminescent Substrate Detection Kit (Enhanced) enables advanced quantitative and reproducible protein immunodetection, with special focus on metabolic research and drug-resistance studies. This in-depth review bridges practical assay design with the latest RCC research insights.

• ACSL1 Modulates Ferroptosis and Platinum Resistance in Ovari

  2026-06-27

  This study reveals that ACSL1 promotes platinum resistance in ovarian cancer by enhancing FSP1 N-myristoylation, which stabilizes FSP1 and inhibits ferroptosis. The findings provide new insights into the interplay between lipid metabolism and ferroptosis regulation, with implications for overcoming chemoresistance in cancer therapy.

• CD28-ARS2 Axis Drives Metabolic Flexibility in CD8+ T Cells

  2026-06-26

  This article examines a recent study revealing how CD28-ARS2–mediated alternative splicing of PKM equips CD8+ T cells with metabolic flexibility crucial for antitumor immunity. The findings clarify mechanisms linking costimulatory signals and glucose metabolism, with implications for immunometabolic interventions in cancer.

• Gli1+ Progenitor Response in Glucocorticoid-Induced Osteopor

  2026-06-26

  This article examines how Gli1+ metaphyseal mesenchymal progenitors (MMPs) mediate bone loss in glucocorticoid-induced osteoporosis, as revealed by recent lineage tracing and single-cell RNA sequencing. The findings clarify the specific progenitor subpopulations affected by glucocorticoids and highlight teriparatide's targeted therapeutic potential to restore bone formation.

• (-)-Blebbistatin: Optimizing Non-Muscle Myosin II Inhibitor

  2026-06-25

  Harness the selectivity of (-)-Blebbistatin to achieve reproducible inhibition of actin-myosin interactions in cell adhesion, migration, and mechanotransduction assays. This guide translates cutting-edge mechanomemory research into actionable protocols, troubleshooting strategies, and workflow enhancements for cytoskeletal dynamics and cardiac muscle studies.

• Salvianolic Acid B Inhibits LH2 to Attenuate Pulmonary Fibro

  2026-06-25

  This study establishes Salvianolic acid B (Dan Shen Suan B) as a potent inhibitor of lysyl hydroxylase 2 (LH2), reducing pathological collagen cross-linking in pulmonary fibrosis. The findings clarify how targeting LH2 with natural compounds disrupts extracellular matrix remodeling, offering a mechanistically grounded antifibrotic approach.

• AICAR: Advancing AMPK-Driven Metabolic and Inflammation Rese

  2026-06-24

  AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) empowers researchers to dissect energy metabolism and inflammation with high reproducibility. Discover how APExBIO’s AICAR enables targeted AMPK activation, robust experimental control, and streamlined troubleshooting in both cellular and animal models.

• Enhanced ECL Detection: Mechanistic Power for Translational

  2026-06-23

  Explore how the ECL Chemiluminescent Substrate Detection Kit (Enhanced) empowers researchers to achieve ultra-sensitive western blot chemiluminescence detection, with a special focus on translational oncology workflows. Bridging mechanistic insights from RCC resistance to expert protocol guidance, this article delivers actionable strategies for elevating protein immunodetection in modern translational science.

• Hexetidine (NSC-17764): Broad-Spectrum Oral Antimicrobial Fa

  2026-06-23

  Hexetidine (NSC-17764) is a broad-spectrum antimicrobial agent with proven efficacy against Gram-positive and Gram-negative bacteria and Candida albicans. As supplied by APExBIO, it is widely used for oral infection control, biofilm inhibition, and dental plaque reduction. This article details its mechanism, benchmarks, and clinical integration with rigorously sourced data.

• Trelagliptin Promotes Osteoblastic Differentiation via RUNX2

  2026-06-22

  This study elucidates a novel role for trelagliptin, a DPP-4 inhibitor, in promoting osteoblastic differentiation by upregulating RUNX2 expression via AMPK signaling in MC3T3-E1 cells. The findings suggest therapeutic implications for osteoporosis, particularly in populations with diabetes, and highlight mechanisms relevant for bone biology research.

• Structural Basis of HCAR3–Agonist Recognition in Lipid Metab

  2026-06-22

  Ye et al. (2025) provide the first high-resolution cryo-EM structures of the hydroxycarboxylic acid receptor 3 (HCAR3) bound to selective agonists, including Acifran ((R)-5-methyl-4-oxo-5-phenyl-4,5-dihydrofuran-2-carboxylic acid). Their work clarifies the molecular determinants of ligand recognition and selectivity, offering a foundation for rational design of hypolipidemic agents targeting metabolic disorders.

• Genotoxicity and Cytotoxicity of Heat-Not-Burn Products vs C

  2026-06-21

  This study comprehensively compares the genotoxic and cytotoxic profiles of heat-not-burn tobacco products and conventional cigarettes using both in vivo and in vitro models. The findings demonstrate that heat-not-burn products induce significantly lower cytotoxicity and genotoxicity, offering valuable evidence for toxicological risk assessment in alternative tobacco technologies.

452 records 13/31 page Previous Next First page 上5页 1112131415 下5页 Last page